Growth Metrics

Gilead Sciences (GILD) Short-term Investments (2016 - 2026)

Gilead Sciences filings provide 16 years of Short-term Investments readings, the most recent being $68.0 million for Q4 2025.

  • On a quarterly basis, Short-term Investments changed N/A to $68.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $68.0 million, a N/A change, with the full-year FY2025 number at $68.0 million, changed N/A from a year prior.
  • Short-term Investments hit $68.0 million in Q4 2025 for Gilead Sciences, up from $19.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $1.6 billion in Q2 2021 to a low of $19.0 million in Q3 2025.
  • Median Short-term Investments over the past 4 years was $973.0 million (2022), compared with a mean of $938.1 million.
  • Biggest five-year swings in Short-term Investments: crashed 87.59% in 2021 and later rose 21.17% in 2023.
  • Gilead Sciences' Short-term Investments stood at $1.2 billion in 2021, then dropped by 17.68% to $973.0 million in 2022, then rose by 21.17% to $1.2 billion in 2023, then tumbled by 94.23% to $68.0 million in 2025.
  • The last three reported values for Short-term Investments were $68.0 million (Q4 2025), $19.0 million (Q3 2025), and $69.0 million (Q2 2025) per Business Quant data.